UCSF-CAPRA score for prostate cancer
Recurrence risk in localized prostate cancer.
Inputs
CompleteAge
PSA (ng/mL)
Biopsy Gleason pattern
Clinical stage T3a
34% or more of biopsy cores positive
Worked calculation
Your values are highlighted.
- Points
When to use
- Newly diagnosed localized prostate cancer.
Pearls and pitfalls
- Each 2-point increase roughly doubles recurrence risk.
Why use
Simple, validated across treatment types.
| Criterion | Points |
|---|---|
| Age: Under 50 | 0 |
| 50 or older | +1 |
| PSA (ng/mL): 6 or lower | 0 |
| 6.1–10 | +1 |
| 10.1–20 | +2 |
| 20.1–30 | +3 |
| Above 30 | +4 |
| Biopsy Gleason pattern: No pattern 4 or 5 | 0 |
| Secondary pattern 4 or 5 | +1 |
| Primary pattern 4 or 5 | +3 |
| Clinical stage T3a | +1 |
| 34% or more of biopsy cores positive | +1 |